Amgen's cholesterol drug Repatha has been given the green light in Europe making it the first in the new PCSK9 inhibitor class approved anywhere in the world.Repatha evolocumab is a human monoclonal antibody that inhibits PCSK9 a protein that reduces the l...
↧